Genotyping and molecular analysis of Enterocytozoon bieneusi isolated from immunocompromised patients in Iran

Hamed Mirjalali1, Hossein Mirhendi2, Ahmad Reza Meamar3

  • 1Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran.

Insights

Enterocytozoon bieneusi, a common opportunistic pathogen, shows distinct genotype distributions in immunocompromised Iranian patients. Genotype D was most frequent overall, while Genotype E was specific to HIV/AIDS and cancer patients.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Microsporidia are opportunistic pathogens, with Enterocytozoon bieneusi frequently infecting immunocompromised individuals.
  • Understanding E. bieneusi genotype prevalence is crucial for managing infections in vulnerable populations.

Purpose of the Study:

  • To determine the distribution of Enterocytozoon bieneusi genotypes in immunocompromised patients in Iran.
  • To investigate potential correlations between E. bieneusi genotypes and immunosuppression types.

Main Methods:

  • Analysis of 329 stool samples from immunocompromised patients.
  • Identification of E. bieneusi using SSU rDNA.
  • Genotyping via Internal Transcribed Spacer (ITS) region sequencing.
  • Phylogenetic analysis of obtained sequences.

Main Results:

  • Genotype D was identified in HIV/AIDS, transplant, and cancer patients.
  • Genotype E was found exclusively in HIV/AIDS and cancer patients.
  • Phylogenetic analysis showed genotype D isolates clustering with human and animal sources, irrespective of immunosuppression type.

Conclusions:

  • Genotype D is the predominant E. bieneusi genotype in Iranian immunocompromised patients.
  • Genotype E appears restricted to HIV/AIDS and cancer patients within this cohort.
  • No direct relationship was observed between E. bieneusi genotypes and the specific type of immunosuppression.